The store will not work correctly when cookies are disabled.
(S)-2-(3-octyl-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide hydrochloride
ID: ALA3627777
Chembl Id: CHEMBL3627777
PubChem CID: 122192898
Max Phase: Preclinical
Molecular Formula: C15H28ClN5O
Molecular Weight: 293.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCc1noc([C@@H]2CCCN2C(=N)N)n1.Cl
Standard InChI: InChI=1S/C15H27N5O.ClH/c1-2-3-4-5-6-7-10-13-18-14(21-19-13)12-9-8-11-20(12)15(16)17;/h12H,2-11H2,1H3,(H3,16,17);1H/t12-;/m0./s1
Standard InChI Key: HYBXJKXKSUCKOQ-YDALLXLXSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 293.42 | Molecular Weight (Monoisotopic): 293.2216 | AlogP: 3.00 | #Rotatable Bonds: 8 |
Polar Surface Area: 92.03 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.22 | CX LogP: 3.70 | CX LogD: 1.23 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.44 | Np Likeness Score: -0.90 |
References
1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL.. (2015) Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors., 25 (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041] |